Page 136 - ESHRE2019

no
disease
cell origin
derived cells
country
phase
start date
final date
no pac.
status
NCT02923375
Graft versus Host Disease
hiPS allog.
mesenquimal stem cells
Australia
I
mar‐17
may‐20
12
active
UMIN000011929
Age‐related macular degeneration
hiPS autol.
retinal pigmented epithelia
Japan
I
sep‐14
sep‐15
1
suspended
UMIN000026003
Exudative age‐related macular degeneration
hiPS allog.
retinal pigmented epithelia
Japan
I
feb‐17
5
active
UMIN000033564
Parkinson's disesase
hiPS allog.
dopaminergic progenitors
Japan
I/II
may‐18
7
recruiting
UMIN000033565
Parkinson's disesase
hiPS allog.
dopaminergic progenitors
Japan
III
2019
7
ongoing
Ischemic heart disease
hiPS autol.
cardiac cells
Japan
I
2019
3
ongoing
Advanced Solid Tumors
hiPS autol.
natural killer cells
USA
I
2019
ongoing
Cancer (immunotherapy)
hiPS autol.
killer T cells
Japan
2019
ongoing
Hematologic malignancies
hiPS aut. engin.
natural killer cells
USA
I
2019
ongoing
Spinal Cord Injury
hiPS allog.
neural precirsors cells
Japan
I
2019
4
ongoing
Corneal diseases
hiPS allog.
corneal‐epithelium‐like‐cell
Japan
I
2019
4
waiting for approval
PCC Stem Cells - ESHRE Vienna 2019
April 2019
Original cell type
11
32
ESC iPSC
PCC Stem Cells - ESHRE Vienna 2019
134
131